Skip to content
healthcare.dev

Abiraterone acetate

NDC 64980-418, Abiraterone acetate, tablet, from Rising Pharma Holdings, Inc..

Product NDC
64980-418
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208371
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-418 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
64980-418-1264980041812120 TABLET in 1 BOTTLE (64980-418-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/54ae5ef9-aea5-484a-a473-863b1397e206
  • NADAC price for package 64980041812

    GET /v1/drugs/nadac/64980041812

Use it

Look up 64980-418 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-418 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-418. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.